Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Reevaluation of the pretransplant assessment of mortality score after allogeneic hematopoietic transplantation.

Au BK, Gooley TA, Armand P, Fang M, Madtes DK, Sorror ML, Boeckh MJ, Gibson CJ, Deeg HJ, Storb R, Appelbaum FR, Chien JW, Martin PJ.

Biol Blood Marrow Transplant. 2015 May;21(5):848-54. doi: 10.1016/j.bbmt.2015.01.011. Epub 2015 Jan 31.

2.

Fluticasone, azithromycin and montelukast therapy in reducing corticosteroid exposure in bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: a case series of eight patients.

Norman BC, Jacobsohn DA, Williams KM, Au BK, Au MA, Lee SJ, Moravec CK, Chien JW.

Bone Marrow Transplant. 2011 Oct;46(10):1369-73. doi: 10.1038/bmt.2010.311. Epub 2010 Dec 6.

3.

Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation.

Au BK, Au MA, Chien JW.

Biol Blood Marrow Transplant. 2011 Jul;17(7):1072-8. doi: 10.1016/j.bbmt.2010.11.018. Epub 2010 Nov 30.

4.

Multicenter validation of a simplified score to predict massive transfusion in trauma.

Cotton BA, Dossett LA, Haut ER, Shafi S, Nunez TC, Au BK, Zaydfudim V, Johnston M, Arbogast P, Young PP.

J Trauma. 2010 Jul;69 Suppl 1:S33-9. doi: 10.1097/TA.0b013e3181e42411.

PMID:
20622617
5.

Room for (performance) improvement: provider-related factors associated with poor outcomes in massive transfusion.

Cotton BA, Dossett LA, Au BK, Nunez TC, Robertson AM, Young PP.

J Trauma. 2009 Nov;67(5):1004-12. doi: 10.1097/TA.0b013e3181bcb2a8.

PMID:
19901661
6.

Exsanguination protocol improves survival after major hepatic trauma.

Zaydfudim V, Dutton WD, Feurer ID, Au BK, Pinson CW, Cotton BA.

Injury. 2010 Jan;41(1):30-4. doi: 10.1016/j.injury.2009.09.019.

PMID:
19800623
7.

Hyperkalemia following massive transfusion in trauma.

Au BK, Dutton WD, Zaydfudim V, Nunez TC, Young PP, Cotton BA.

J Surg Res. 2009 Dec;157(2):284-9. doi: 10.1016/j.jss.2009.05.009. Epub 2009 Jun 6.

PMID:
19765727
8.

Vaccine-induced immunity circumvented by typical Mycobacterium tuberculosis Beijing strains.

Kremer K, van-der-Werf MJ, Au BK, Anh DD, Kam KM, van-Doorn HR, Borgdorff MW, van-Soolingen D.

Emerg Infect Dis. 2009 Feb;15(2):335-9.

9.

Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications.

Cotton BA, Au BK, Nunez TC, Gunter OL, Robertson AM, Young PP.

J Trauma. 2009 Jan;66(1):41-8; discussion 48-9. doi: 10.1097/TA.0b013e31819313bb.

PMID:
19131804
10.

Optimizing outcomes in damage control resuscitation: identifying blood product ratios associated with improved survival.

Gunter OL Jr, Au BK, Isbell JM, Mowery NT, Young PP, Cotton BA.

J Trauma. 2008 Sep;65(3):527-34. doi: 10.1097/TA.0b013e3181826ddf.

PMID:
18784564
11.

Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization.

Cotton BA, Gunter OL, Isbell J, Au BK, Robertson AM, Morris JA Jr, St Jacques P, Young PP.

J Trauma. 2008 May;64(5):1177-82; discussion 1182-3. doi: 10.1097/TA.0b013e31816c5c80.

PMID:
18469638
13.

Utility of mycobacterial interspersed repetitive unit typing for differentiating multidrug-resistant Mycobacterium tuberculosis isolates of the Beijing family.

Kam KM, Yip CW, Tse LW, Wong KL, Lam TK, Kremer K, Au BK, van Soolingen D.

J Clin Microbiol. 2005 Jan;43(1):306-13.

Supplemental Content

Support Center